John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
PUT
Essex Property Trust
ESS
$18.8B
| $475K | ﹤0.01% |
2,000
+1,000
| +100% | +$231K |
|
2552
CALL
STAAR Surgical
STAA
$1.16B
| $475K | ﹤0.01% |
+6,000
| New | +$439K |
|
2553
CALL
L3Harris
LHX
$48.8B
| $473K | ﹤0.01% |
2,500
-3,700
| -60% | -$677K |
|
|
PBCT
2554
DELISTED
People's United Financial Inc
PBCT
| $473K | ﹤0.01% |
36,567
-532,686
| -94% | -$6.4M |
|
2555
Cirrus Logic
CRUS
$5.58B
| $472K | ﹤0.01% |
5,747
-188,031
| -97% | -$14.1M |
|
2556
PUT
Travel + Leisure Co
TNL
$4.51B
| $471K | ﹤0.01% |
10,500
-13,500
| -56% | -$530K |
|
2557
CALL
DaVita
DVA
$11.3B
| $470K | ﹤0.01% |
+4,000
| New | +$407K |
|
2558
Interparfums
IPAR
$3.73B
| $470K | ﹤0.01% |
7,768
-7,084
| -48% | -$356K |
|
2559
PUT
AngloGold Ashanti
AU
$62.4B
| $468K | ﹤0.01% |
+20,700
| New | +$497K |
|
2560
CALL
McCormick & Company Non-Voting
MKC
$14.6B
| $468K | ﹤0.01% |
+4,900
| New | +$462K |
|
2561
Vera Bradley
VRA
$91M
| $467K | ﹤0.01% |
58,688
-222,103
| -79% | -$1.68M |
|
2562
PUT
Allegion
ALLE
$13.6B
| $466K | ﹤0.01% |
+4,000
| New | +$435K |
|
2563
PUT
Ameriprise Financial
AMP
$49.5B
| $466K | ﹤0.01% |
+2,400
| New | +$430K |
|
2564
CALL
Cboe Global Markets
CBOE
$32.3B
| $466K | ﹤0.01% |
5,000
-26,700
| -84% | -$2.34M |
|
2565
CALL
HF Sinclair
DINO
$16.6B
| $465K | ﹤0.01% |
18,000
-4,700
| -21% | -$106K |
|
|
FRGI
2566
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $465K | ﹤0.01% |
40,792
-13,857
| -25% | -$153K |
|
2567
Genco Shipping & Trading
GNK
$1.19B
| $463K | ﹤0.01% |
+62,900
| New | +$458K |
|
2568
CALL
Chubb
CB
$132B
| $462K | ﹤0.01% |
3,000
+1,000
| +50% | +$140K |
|
2569
Altimmune
ALT
$622M
| $461K | ﹤0.01% |
40,852
-611,316
| -94% | -$7.2M |
|
2570
CALL
Corning
GLW
$127B
| $461K | ﹤0.01% |
+12,800
| New | +$455K |
|
2571
PUT
Digital Realty Trust
DLR
$71.2B
| $460K | ﹤0.01% |
+3,300
| New | +$472K |
|
2572
PUT
Knight Transportation
KNX
$11.1B
| $460K | ﹤0.01% |
+11,000
| New | +$448K |
|
2573
CALL
Levi Strauss
LEVI
$8.12B
| $460K | ﹤0.01% |
22,900
-91,300
| -80% | -$1.63M |
|
2574
CALL
Ambarella
AMBA
$3.1B
| $459K | ﹤0.01% |
5,000
+500
| +11% | +$35K |
|
2575
Interface
TILE
$2.25B
| $459K | ﹤0.01% |
43,744
+16,683
| +62% | +$133K |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.